Department of Radiology
Found 7 results
Filters: Keyword is Dipeptides  [Clear All Filters]
2023
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L et al..  2023.  Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).. Eur J Nucl Med Mol Imaging. 50(9):2830-2845.
Hope TA, Antonarakis ES, Bodei L, Calais J, Iravani A, Jacene H, Koo PJ, Morgans AK, Osborne JR, Tagawa ST et al..  2023.  SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.. J Nucl Med. 64(9):1417-1423.
2013
Jeitner TM, Battaile K, Cooper AJL.  2013.  γ-Glutamylamines and neurodegenerative diseases.. Amino Acids. 44(1):129-42.
2008
Wang X-L, Nguyen T, Gillespie D, Jensen R, Lu Z-R.  2008.  A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery.. Biomaterials. 29(1):15-22.
2006
Galande AK, Hilderbrand SA, Weissleder R, Tung C-H.  2006.  Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core.. J Med Chem. 49(15):4715-20.
2002
Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJL, Ratan RR, M Beal F et al..  2002.  Therapeutic effects of cystamine in a murine model of Huntington's disease.. J Neurosci. 22(20):8942-50.
2001
Jeitner TM, Bogdanov MB, Matson WR, Daikhin Y, Yudkoff M, Folk JE, Steinman L, Browne SE, Beal MF, Blass JP et al..  2001.  N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.. J Neurochem. 79(5):1109-12.